Thomas Schinecker Dr | |
|---|---|
| Born | April 23, 1975[1] |
| Nationality | Austria |
| Citizenship | Austrian, German |
| Education | University of Salzburg New York University |
| Occupation | CEO of Roche |
| Children | 3 |
Thomas Schinecker (born April 23, 1975 in Simbach am Inn) is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group.[2][3][4]
- ^ "Curriculum Vitae" (PDF). Retrieved 24 April 2023.
- ^ "Roche's chief executive to step down and become chair". Financial Times. 2022-07-21. Archived from the original on 2023-04-25. Retrieved 2023-04-25.
- ^ OLOF-ORS, Nathalie. "Roche Set For Shake-up At The Top". www.barrons.com. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
- ^ "Pharma: Der neue CEO Thomas Schinecker muss Roche wieder vorwärtsbringen". Handelszeitung (in Swiss High German). Archived from the original on 2023-04-02. Retrieved 2023-05-30.